All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • vudalimabPhase 22 trials

    Xencor, Inc. · Ovarian Cancer, Clear Cell Carcinoma, Endometrial Cancer

  • WGI-0301Phase 22 trials

    Zhejiang Haichang Biotech Co., Ltd. · Advanced Hepatocellular Carcinoma (HCC), Hepato Cellular Carcinoma (HCC), Renal Cell Cancer

  • WJB001Phase 22 trials

    Wigen Biomedicine Technology (Shanghai) Co., Ltd. · Advanced Solid Tumor, Advanced Solid Tumors

  • XNW27011ASP546CPhase 22 trials

    Astellas · Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic

  • MediLink Therapeutics (Suzhou) Co., Ltd. · NSCLC, Breast Cancer, HNSCC

  • ZalifrelimabPhase 22 trials

    ImmunoGenesis · Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer

  • ZEN003694ZEN-3694Phase 22 trials

    Zenith Epigenetics · mCRPC, Metastatic Castration-Resistant Prostate Cancer

  • ZGGS18Phase 22 trials

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Advanced Solid Tumor

  • Chengdu Zenitar Biomedical Technology Co., Ltd · Advanced Solid Tumor

  • AB-2100Integrated Circuit T cellsPhase 21 trial

    Arsenal Biosciences, Inc. · Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Recurrence

  • AB680Phase 21 trial

    Arcus Biosciences, Inc. · Metastatic Colorectal Cancer

  • ABL103Phase 21 trial

    ABL Bio, Inc. · Solid Tumors

  • ABO2011ABOD2011Phase 21 trial

    Suzhou Abogen Biosciences Co., Ltd. · Solid Tumor, Adult

  • ABP1011TPhase 21 trial

    Shanghai AB PharmaTech Ltd. · SCLC, Extensive Stage, Advanced Solid Tumors

  • ABSK141Phase 21 trial

    Abbisko Therapeutics Co, Ltd · Solid Tumors, Adult

  • ABT-101DBPR112Phase 21 trial

    Anbogen Therapeutics, Inc. · Advanced Solid Tumor, Non Small Cell Lung Cancer, HER2 Mutations

  • ACE-86225106Phase 21 trial

    Acerand Therapeutics (Shanghai) Limited · Solid Tumor, Adult, BRCA1 Mutation, BRCA2 Mutation

  • ACR-2316Phase 21 trial

    Acrivon Therapeutics · Specific Advanced Solid Tumors

  • ACR-368prexasertibPhase 21 trial

    Acrivon Therapeutics · Endometrial Adenocarcinoma

  • ACT001Phase 21 trial

    Accendatech USA Inc. · Recurrent Glioblastoma Multiforme(GBM)

  • AD1208Phase 21 trial

    Avelos Therapeutics Inc. · Solid Tumor, Adult, Tumor, Solid, Solid Tumor

  • AdAPT-001Phase 21 trial

    EpicentRx, Inc. · Solid Tumor, Adult, Cancer, Neoplasms

  • adebeliizumabPhase 21 trial

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer

  • ADI-212Phase 21 trial

    Adicet Therapeutics · Prostate Cancer Metastatic

  • AFNT-211Phase 21 trial

    Affini-T Therapeutics, Inc. · Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer, Colorectal Cancer

  • AGS 22M6EAGS-22CEPhase 21 trial

    Merck & Co. · Bladder Cancer

  • AI-081Phase 21 trial

    OncoC4, Inc. · Advanced Solid Tumor

  • Aldoxorubicin HClPhase 21 trial

    ImmunityBio, Inc. · Pancreatic Cancer

  • ALK202Phase 21 trial

    Shanghai Allink Biotherapeutics Co., Ltd. · NSCLC (Advanced Non-small Cell Lung Cancer)

  • ALMB-0168Phase 21 trial

    AlaMab Therapeutics (Shanghai) Inc. · Advanced Solid Tumors With Bone Only Metastasis

  • Alomnertinib MesilatePhase 21 trial

    Shanghai Hengrui Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer

  • AMO959BY1298, BY101298Phase 21 trial

    Novartis · PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy

  • AMP945Phase 21 trial

    Amplia Therapeutics Limited · Pancreatic Cancer, PDAC, Pancreatic Ductal Adenocarcinoma

  • AMT-253Phase 21 trial

    Multitude Therapeutics Inc. · Malignant Melanoma, Advanced Solid Tumors

  • AMT-676Phase 21 trial

    Multitude Therapeutics Inc. · Colorectal Cancer

  • AMXI-5001Phase 21 trial

    AtlasMedx, Incorporated · Advanced Malignant Neoplasm, Breast Cancer, Ovarian Cancer

  • and CarboplatinPhase 21 trial

    CrystalGenomics, Inc. · Non Squamous Non Small Cell Lung Cancer

  • ANO31905Phase 21 trial

    Anova Innovation Limited · Pancreatic Cancer

  • ANS014004Phase 21 trial

    Beijing Pearl Biotechnology Limited Liability Company · Non-Small Cell Lung Cancer, EGFR Mutation, Metastatic Lung Cancer

  • ANS02Phase 21 trial

    Avistone Biotechnology Co., Ltd. · Non-Small Cell Lung Cancer

  • ANV600Phase 21 trial

    Anaveon AG · Advanced Solid Tumor

  • AP203Phase 21 trial

    AP Biosciences Inc. · Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC)

  • AP402Phase 21 trial

    AP Biosciences Inc. · Advanced Solid Tumor

  • APL-101Phase 21 trial

    Apollomics Inc. · Solid Tumors, Advanced Cancer, Renal Cancer

  • ART0380Phase 21 trial

    Artios Pharma Ltd · Advanced Cancer, Metastatic Cancer, Ovarian Cancer

  • ART6043Phase 21 trial

    Artios Pharma Ltd · Advanced Solid Tumor, Metastatic Solid Tumor

  • ARV-6723Phase 21 trial

    Arvinas Inc. · Advanced Solid Tumor

  • ARV-806Phase 21 trial

    Arvinas Inc. · KRAS G12D Mutation, Advanced Solid Cancer

  • ARX788Phase 21 trial

    Ambrx, Inc. · HER2 Positive Metastatic Breast Cancer

  • AS1986NSPhase 21 trial

    Antelope Surgical Solutions, Inc · Prostate Cancer, Prostate Cancer (Adenocarcinoma), Fluorescence Imaging

NewerPage 14 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.